Exercise and survival benefit in cancer patients: evidence from a comprehensive meta-analysis

Cancer remains a major global health challenge, and growing evidence suggests that physical activity is a key modifiable factor that may improve survival outcomes in cancer patients. However, a comprehensive, large-scale synthesis of the effects of post-diagnosis physical activity across multiple ca...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	GeroScience Ročník 47; číslo 3; s. 5235 - 5255
Hlavní autori:	Ungvari, Zoltan, Fekete, Mónika, Varga, Péter, Munkácsy, Gyöngyi, Fekete, János Tibor, Lehoczki, Andrea, Buda, Annamaria, Kiss, Csaba, Ungvari, Anna, Győrffy, Balázs
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Cham Springer International Publishing 01.06.2025 Springer Nature B.V
Predmet:	Adults Aging Analysis Biomedical and Life Sciences Breast cancer Cancer Cell Biology Clinical outcomes Colorectal cancer Colorectal carcinoma Diagnosis Exercise Female Geriatrics/Gerontology Humans Life Sciences Lung cancer Male Medical diagnosis Medical prognosis Meta-analysis Molecular Medicine Mortality Neoplasms - mortality Original Original Article Patients Physical activity Physical fitness Prostate Prostate cancer Public health Sensitivity analysis Skin Skin cancer Survival Physical activity Lung cancer Colorectal cancer Breast cancer Survival Prostate cancer Skin cancer
ISSN:	2509-2723, 2509-2715, 2509-2723
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Cancer remains a major global health challenge, and growing evidence suggests that physical activity is a key modifiable factor that may improve survival outcomes in cancer patients. However, a comprehensive, large-scale synthesis of the effects of post-diagnosis physical activity across multiple cancer types remains lacking. This meta-analysis aims to systematically evaluate the association between physical activity and survival in patients diagnosed with breast, lung, prostate, colorectal, and skin cancers. We conducted a comprehensive search in PubMed, Web of Science, Scopus, and Cochrane Library for studies on physical activity and cancer survival. Eligible studies (January 2000–November 2024) included adults (≥ 18 years) with breast, lung, prostate, colorectal, or skin cancer. Only prospective cohort and case–control studies reporting hazard ratios (HRs) with 95% confidence intervals (CIs) for overall or cancer-specific mortality were included, with a minimum sample size of 100 and at least six months of follow-up. Meta-analysis was performed using metaanalysisonline.com, applying random-effects models and assessing heterogeneity via the I 2 statistic. Sensitivity analyses and publication bias (Egger’s test, funnel plots) were evaluated. The meta-analysis included 151 cohorts with almost 1.5 million cancer patients. Post-diagnosis physical activity was associated with significantly lower cancer-specific mortality across all five cancer types. The greatest benefit was observed in breast cancer, with a pooled hazard ratio (HR) of 0.69 (95% CI: 0.63–0.75), followed by prostate cancer (HR: 0.73, 95% CI: 0.62–0.87). Lung cancer patients who engaged in physical activity had a 24% lower risk of cancer-specific death (HR: 0.76, 95% CI: 0.69–0.84), while colorectal cancer patients experienced a similar benefit (HR: 0.71, 95% CI: 0.63–0.80). In skin cancer, physical activity was associated with a non-significant reduction in mortality (HR: 0.86, 95% CI: 0.71–1.05). These findings provide robust evidence supporting the survival benefits of post-diagnosis physical activity in cancer patients, particularly for breast, prostate, lung, and colorectal cancers. The results underscore the potential for incorporating structured physical activity interventions into oncological care to improve long-term patient outcomes.
AbstractList	Cancer remains a major global health challenge, and growing evidence suggests that physical activity is a key modifiable factor that may improve survival outcomes in cancer patients. However, a comprehensive, large-scale synthesis of the effects of post-diagnosis physical activity across multiple cancer types remains lacking. This meta-analysis aims to systematically evaluate the association between physical activity and survival in patients diagnosed with breast, lung, prostate, colorectal, and skin cancers. We conducted a comprehensive search in PubMed, Web of Science, Scopus, and Cochrane Library for studies on physical activity and cancer survival. Eligible studies (January 2000–November 2024) included adults (≥ 18 years) with breast, lung, prostate, colorectal, or skin cancer. Only prospective cohort and case–control studies reporting hazard ratios (HRs) with 95% confidence intervals (CIs) for overall or cancer-specific mortality were included, with a minimum sample size of 100 and at least six months of follow-up. Meta-analysis was performed using metaanalysisonline.com, applying random-effects models and assessing heterogeneity via the I2 statistic. Sensitivity analyses and publication bias (Egger’s test, funnel plots) were evaluated. The meta-analysis included 151 cohorts with almost 1.5 million cancer patients. Post-diagnosis physical activity was associated with significantly lower cancer-specific mortality across all five cancer types. The greatest benefit was observed in breast cancer, with a pooled hazard ratio (HR) of 0.69 (95% CI: 0.63–0.75), followed by prostate cancer (HR: 0.73, 95% CI: 0.62–0.87). Lung cancer patients who engaged in physical activity had a 24% lower risk of cancer-specific death (HR: 0.76, 95% CI: 0.69–0.84), while colorectal cancer patients experienced a similar benefit (HR: 0.71, 95% CI: 0.63–0.80). In skin cancer, physical activity was associated with a non-significant reduction in mortality (HR: 0.86, 95% CI: 0.71–1.05). These findings provide robust evidence supporting the survival benefits of post-diagnosis physical activity in cancer patients, particularly for breast, prostate, lung, and colorectal cancers. The results underscore the potential for incorporating structured physical activity interventions into oncological care to improve long-term patient outcomes. Cancer remains a major global health challenge, and growing evidence suggests that physical activity is a key modifiable factor that may improve survival outcomes in cancer patients. However, a comprehensive, large-scale synthesis of the effects of post-diagnosis physical activity across multiple cancer types remains lacking. This meta-analysis aims to systematically evaluate the association between physical activity and survival in patients diagnosed with breast, lung, prostate, colorectal, and skin cancers. We conducted a comprehensive search in PubMed, Web of Science, Scopus, and Cochrane Library for studies on physical activity and cancer survival. Eligible studies (January 2000-November 2024) included adults (≥ 18 years) with breast, lung, prostate, colorectal, or skin cancer. Only prospective cohort and case-control studies reporting hazard ratios (HRs) with 95% confidence intervals (CIs) for overall or cancer-specific mortality were included, with a minimum sample size of 100 and at least six months of follow-up. Meta-analysis was performed using metaanalysisonline.com, applying random-effects models and assessing heterogeneity via the I statistic. Sensitivity analyses and publication bias (Egger's test, funnel plots) were evaluated. The meta-analysis included 151 cohorts with almost 1.5 million cancer patients. Post-diagnosis physical activity was associated with significantly lower cancer-specific mortality across all five cancer types. The greatest benefit was observed in breast cancer, with a pooled hazard ratio (HR) of 0.69 (95% CI: 0.63-0.75), followed by prostate cancer (HR: 0.73, 95% CI: 0.62-0.87). Lung cancer patients who engaged in physical activity had a 24% lower risk of cancer-specific death (HR: 0.76, 95% CI: 0.69-0.84), while colorectal cancer patients experienced a similar benefit (HR: 0.71, 95% CI: 0.63-0.80). In skin cancer, physical activity was associated with a non-significant reduction in mortality (HR: 0.86, 95% CI: 0.71-1.05). These findings provide robust evidence supporting the survival benefits of post-diagnosis physical activity in cancer patients, particularly for breast, prostate, lung, and colorectal cancers. The results underscore the potential for incorporating structured physical activity interventions into oncological care to improve long-term patient outcomes. Cancer remains a major global health challenge, and growing evidence suggests that physical activity is a key modifiable factor that may improve survival outcomes in cancer patients. However, a comprehensive, large-scale synthesis of the effects of post-diagnosis physical activity across multiple cancer types remains lacking. This meta-analysis aims to systematically evaluate the association between physical activity and survival in patients diagnosed with breast, lung, prostate, colorectal, and skin cancers. We conducted a comprehensive search in PubMed, Web of Science, Scopus, and Cochrane Library for studies on physical activity and cancer survival. Eligible studies (January 2000-November 2024) included adults (≥ 18 years) with breast, lung, prostate, colorectal, or skin cancer. Only prospective cohort and case-control studies reporting hazard ratios (HRs) with 95% confidence intervals (CIs) for overall or cancer-specific mortality were included, with a minimum sample size of 100 and at least six months of follow-up. Meta-analysis was performed using metaanalysisonline.com, applying random-effects models and assessing heterogeneity via the I2 statistic. Sensitivity analyses and publication bias (Egger's test, funnel plots) were evaluated. The meta-analysis included 151 cohorts with almost 1.5 million cancer patients. Post-diagnosis physical activity was associated with significantly lower cancer-specific mortality across all five cancer types. The greatest benefit was observed in breast cancer, with a pooled hazard ratio (HR) of 0.69 (95% CI: 0.63-0.75), followed by prostate cancer (HR: 0.73, 95% CI: 0.62-0.87). Lung cancer patients who engaged in physical activity had a 24% lower risk of cancer-specific death (HR: 0.76, 95% CI: 0.69-0.84), while colorectal cancer patients experienced a similar benefit (HR: 0.71, 95% CI: 0.63-0.80). In skin cancer, physical activity was associated with a non-significant reduction in mortality (HR: 0.86, 95% CI: 0.71-1.05). These findings provide robust evidence supporting the survival benefits of post-diagnosis physical activity in cancer patients, particularly for breast, prostate, lung, and colorectal cancers. The results underscore the potential for incorporating structured physical activity interventions into oncological care to improve long-term patient outcomes.Cancer remains a major global health challenge, and growing evidence suggests that physical activity is a key modifiable factor that may improve survival outcomes in cancer patients. However, a comprehensive, large-scale synthesis of the effects of post-diagnosis physical activity across multiple cancer types remains lacking. This meta-analysis aims to systematically evaluate the association between physical activity and survival in patients diagnosed with breast, lung, prostate, colorectal, and skin cancers. We conducted a comprehensive search in PubMed, Web of Science, Scopus, and Cochrane Library for studies on physical activity and cancer survival. Eligible studies (January 2000-November 2024) included adults (≥ 18 years) with breast, lung, prostate, colorectal, or skin cancer. Only prospective cohort and case-control studies reporting hazard ratios (HRs) with 95% confidence intervals (CIs) for overall or cancer-specific mortality were included, with a minimum sample size of 100 and at least six months of follow-up. Meta-analysis was performed using metaanalysisonline.com, applying random-effects models and assessing heterogeneity via the I2 statistic. Sensitivity analyses and publication bias (Egger's test, funnel plots) were evaluated. The meta-analysis included 151 cohorts with almost 1.5 million cancer patients. Post-diagnosis physical activity was associated with significantly lower cancer-specific mortality across all five cancer types. The greatest benefit was observed in breast cancer, with a pooled hazard ratio (HR) of 0.69 (95% CI: 0.63-0.75), followed by prostate cancer (HR: 0.73, 95% CI: 0.62-0.87). Lung cancer patients who engaged in physical activity had a 24% lower risk of cancer-specific death (HR: 0.76, 95% CI: 0.69-0.84), while colorectal cancer patients experienced a similar benefit (HR: 0.71, 95% CI: 0.63-0.80). In skin cancer, physical activity was associated with a non-significant reduction in mortality (HR: 0.86, 95% CI: 0.71-1.05). These findings provide robust evidence supporting the survival benefits of post-diagnosis physical activity in cancer patients, particularly for breast, prostate, lung, and colorectal cancers. The results underscore the potential for incorporating structured physical activity interventions into oncological care to improve long-term patient outcomes. Cancer remains a major global health challenge, and growing evidence suggests that physical activity is a key modifiable factor that may improve survival outcomes in cancer patients. However, a comprehensive, large-scale synthesis of the effects of post-diagnosis physical activity across multiple cancer types remains lacking. This meta-analysis aims to systematically evaluate the association between physical activity and survival in patients diagnosed with breast, lung, prostate, colorectal, and skin cancers. We conducted a comprehensive search in PubMed, Web of Science, Scopus, and Cochrane Library for studies on physical activity and cancer survival. Eligible studies (January 2000–November 2024) included adults (≥ 18 years) with breast, lung, prostate, colorectal, or skin cancer. Only prospective cohort and case–control studies reporting hazard ratios (HRs) with 95% confidence intervals (CIs) for overall or cancer-specific mortality were included, with a minimum sample size of 100 and at least six months of follow-up. Meta-analysis was performed using metaanalysisonline.com, applying random-effects models and assessing heterogeneity via the I 2 statistic. Sensitivity analyses and publication bias (Egger’s test, funnel plots) were evaluated. The meta-analysis included 151 cohorts with almost 1.5 million cancer patients. Post-diagnosis physical activity was associated with significantly lower cancer-specific mortality across all five cancer types. The greatest benefit was observed in breast cancer, with a pooled hazard ratio (HR) of 0.69 (95% CI: 0.63–0.75), followed by prostate cancer (HR: 0.73, 95% CI: 0.62–0.87). Lung cancer patients who engaged in physical activity had a 24% lower risk of cancer-specific death (HR: 0.76, 95% CI: 0.69–0.84), while colorectal cancer patients experienced a similar benefit (HR: 0.71, 95% CI: 0.63–0.80). In skin cancer, physical activity was associated with a non-significant reduction in mortality (HR: 0.86, 95% CI: 0.71–1.05). These findings provide robust evidence supporting the survival benefits of post-diagnosis physical activity in cancer patients, particularly for breast, prostate, lung, and colorectal cancers. The results underscore the potential for incorporating structured physical activity interventions into oncological care to improve long-term patient outcomes. Cancer remains a major global health challenge, and growing evidence suggests that physical activity is a key modifiable factor that may improve survival outcomes in cancer patients. However, a comprehensive, large-scale synthesis of the effects of post-diagnosis physical activity across multiple cancer types remains lacking. This meta-analysis aims to systematically evaluate the association between physical activity and survival in patients diagnosed with breast, lung, prostate, colorectal, and skin cancers. We conducted a comprehensive search in PubMed, Web of Science, Scopus, and Cochrane Library for studies on physical activity and cancer survival. Eligible studies (January 2000–November 2024) included adults (≥ 18 years) with breast, lung, prostate, colorectal, or skin cancer. Only prospective cohort and case–control studies reporting hazard ratios (HRs) with 95% confidence intervals (CIs) for overall or cancer-specific mortality were included, with a minimum sample size of 100 and at least six months of follow-up. Meta-analysis was performed using metaanalysisonline.com, applying random-effects models and assessing heterogeneity via the I 2 statistic. Sensitivity analyses and publication bias (Egger’s test, funnel plots) were evaluated. The meta-analysis included 151 cohorts with almost 1.5 million cancer patients. Post-diagnosis physical activity was associated with significantly lower cancer-specific mortality across all five cancer types. The greatest benefit was observed in breast cancer, with a pooled hazard ratio (HR) of 0.69 (95% CI: 0.63–0.75), followed by prostate cancer (HR: 0.73, 95% CI: 0.62–0.87). Lung cancer patients who engaged in physical activity had a 24% lower risk of cancer-specific death (HR: 0.76, 95% CI: 0.69–0.84), while colorectal cancer patients experienced a similar benefit (HR: 0.71, 95% CI: 0.63–0.80). In skin cancer, physical activity was associated with a non-significant reduction in mortality (HR: 0.86, 95% CI: 0.71–1.05). These findings provide robust evidence supporting the survival benefits of post-diagnosis physical activity in cancer patients, particularly for breast, prostate, lung, and colorectal cancers. The results underscore the potential for incorporating structured physical activity interventions into oncological care to improve long-term patient outcomes. Cancer remains a major global health challenge, and growing evidence suggests that physical activity is a key modifiable factor that may improve survival outcomes in cancer patients. However, a comprehensive, large-scale synthesis of the effects of post-diagnosis physical activity across multiple cancer types remains lacking. This meta-analysis aims to systematically evaluate the association between physical activity and survival in patients diagnosed with breast, lung, prostate, colorectal, and skin cancers. We conducted a comprehensive search in PubMed, Web of Science, Scopus, and Cochrane Library for studies on physical activity and cancer survival. Eligible studies (January 2000–November 2024) included adults (≥ 18 years) with breast, lung, prostate, colorectal, or skin cancer. Only prospective cohort and case–control studies reporting hazard ratios (HRs) with 95% confidence intervals (CIs) for overall or cancer-specific mortality were included, with a minimum sample size of 100 and at least six months of follow-up. Meta-analysis was performed using metaanalysisonline.com, applying random-effects models and assessing heterogeneity via the I2 statistic. Sensitivity analyses and publication bias (Egger’s test, funnel plots) were evaluated. The meta-analysis included 151 cohorts with almost 1.5 million cancer patients. Post-diagnosis physical activity was associated with significantly lower cancer-specific mortality across all five cancer types. The greatest benefit was observed in breast cancer, with a pooled hazard ratio (HR) of 0.69 (95% CI: 0.63–0.75), followed by prostate cancer (HR: 0.73, 95% CI: 0.62–0.87). Lung cancer patients who engaged in physical activity had a 24% lower risk of cancer-specific death (HR: 0.76, 95% CI: 0.69–0.84), while colorectal cancer patients experienced a similar benefit (HR: 0.71, 95% CI: 0.63–0.80). In skin cancer, physical activity was associated with a non-significant reduction in mortality (HR: 0.86, 95% CI: 0.71–1.05). These findings provide robust evidence supporting the survival benefits of post-diagnosis physical activity in cancer patients, particularly for breast, prostate, lung, and colorectal cancers. The results underscore the potential for incorporating structured physical activity interventions into oncological care to improve long-term patient outcomes.
Author	Győrffy, Balázs Ungvari, Zoltan Varga, Péter Fekete, Mónika Kiss, Csaba Ungvari, Anna Munkácsy, Gyöngyi Buda, Annamaria Fekete, János Tibor Lehoczki, Andrea
Author_xml	– sequence: 1 givenname: Zoltan surname: Ungvari fullname: Ungvari, Zoltan organization: Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Stephenson Cancer Center, University of Oklahoma, Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences Center, International Training Program in Geroscience, Doctoral College, Health Sciences Division/Institute of Preventive Medicine and Public Health, Semmelweis University – sequence: 2 givenname: Mónika surname: Fekete fullname: Fekete, Mónika organization: Institute of Preventive Medicine and Public Health, Semmelweis University, Semmelweis University, Jozsef Fodor Center for Prevention and Healthy Aging, Semmelweis University – sequence: 3 givenname: Péter surname: Varga fullname: Varga, Péter organization: Institute of Preventive Medicine and Public Health, Semmelweis University, Semmelweis University, Jozsef Fodor Center for Prevention and Healthy Aging, Semmelweis University, Doctoral College, Health Sciences Division, Semmelweis University – sequence: 4 givenname: Gyöngyi surname: Munkácsy fullname: Munkácsy, Gyöngyi organization: Dept. Of Bioinformatics, Semmelweis University, Cancer Biomarker Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences – sequence: 5 givenname: János Tibor surname: Fekete fullname: Fekete, János Tibor organization: Dept. Of Bioinformatics, Semmelweis University, Cancer Biomarker Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences – sequence: 6 givenname: Andrea surname: Lehoczki fullname: Lehoczki, Andrea organization: Institute of Preventive Medicine and Public Health, Semmelweis University, Semmelweis University, Jozsef Fodor Center for Prevention and Healthy Aging, Semmelweis University, Doctoral College, Health Sciences Division, Semmelweis University – sequence: 7 givenname: Annamaria surname: Buda fullname: Buda, Annamaria organization: Institute of Preventive Medicine and Public Health, Semmelweis University, Semmelweis University, Jozsef Fodor Center for Prevention and Healthy Aging, Semmelweis University, Doctoral College, Health Sciences Division, Semmelweis University – sequence: 8 givenname: Csaba surname: Kiss fullname: Kiss, Csaba organization: Dept. Of Bioinformatics, Semmelweis University, Cancer Biomarker Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences – sequence: 9 givenname: Anna orcidid: 0009-0001-5053-2828 surname: Ungvari fullname: Ungvari, Anna email: Ungann2004@gmail.com organization: Institute of Preventive Medicine and Public Health, Semmelweis University, Semmelweis University – sequence: 10 givenname: Balázs surname: Győrffy fullname: Győrffy, Balázs organization: Dept. Of Bioinformatics, Semmelweis University, Cancer Biomarker Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Dept. Of Biophysics, Medical School, University of Pecs
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/40220151$$D View this record in MEDLINE/PubMed
BookMark	eNp9UU1v1TAQtFARLY_-AQ7IEhcuAa8df4QLqqryIVXiAkdk-Tmb1lViP-wkov8el9dC6aEnr9Yzo9mZ5-QgpoiEvAT2FhjT7wqAkLphXDYMVFunJ-SIS9Y1XHNxcG8-JMelXDHGQCslGHtGDlvGOQMJR-TH2S_MPhSkLva0LHkNqxvpFiMOYaYhUu-ix0x3bg4Y5_Ke4hp6rDs65DRRR32adhkvMZawIp1wdo2LbrwuobwgTwc3Fjy-fTfk-8ezb6efm_Ovn76cnpw3vtV6bkBpYL1gnVFG9R4G7zqve2lk6-UA1S2Cb40apARvuOO9kaLuda-3bNuB2JAPe93dsp2w99VodqPd5TC5fG2TC_b_nxgu7UVaLXAwVaetCm9uFXL6uWCZ7RSKx3F0EdNSrADTtUqomuCGvH4AvUpLrhdXFJeyFUJ3vKJe3bf018td9BVg9gCfUykZB-vDXENONw7DaIHZm6Ltvmhbi7Z_irasUvkD6p36oySxJ5UKjheY_9l-hPUbcOa6Lg
CitedBy_id	crossref_primary_10_3389_or_2025_1645505
Cites_doi	10.3389/pore.2024.1611623 10.1093/jnci/djaa046 10.1158/1055-9965.2233.13.12 10.1200/JCO.2014.58.1355 10.1097/JTO.0b013e3182397b3e 10.1158/1055-9965.Epi-09-0538 10.1111/1759-7714.15272 10.1002/ijc.28659 10.1002/cncr.22201 10.1007/s11357-024-01384-w 10.1152/ajpheart.00416.2017 10.1158/1055-9965.Epi-21-0120 10.1245/s10434-015-4967-4 10.3945/ajcn.2008.26717D 10.1016/j.jshs.2023.07.002 10.3390/jcm9061775 10.1111/ejh.12395 10.1055/s-0034-1398531 10.1016/j.maturitas.2024.107977 10.1038/s41598-020-67431-6 10.1038/bmt.2016.73 10.1007/s11427-024-2657-y 10.1093/gerona/61.3.211 10.1111/acel.13527 10.1519/JSC.0000000000004020 10.1002/cam4.5831 10.1016/j.cmet.2022.11.001 10.1186/s12905-022-01614-3 10.1002/ijc.30281 10.1007/s10552-010-9714-3 10.1002/ijc.24155 10.1007/s10549-011-1770-1 10.1002/ijc.34903 10.1007/s11357-024-01222-z 10.1123/jpah.5.6.918 10.1016/j.redox.2016.10.003 10.1200/JCO.2006.06.0863 10.1136/bjsports-2021-105315 10.1007/s12032-010-9536-x 10.7717/peerj.18892 10.1249/MSS.0b013e3181c47b65 10.1016/j.breast.2019.02.001 10.1177/1534735419839466 10.1016/j.clcc.2013.06.005 10.1038/s41577-023-00943-0 10.1200/JCO.2012.45.9735 10.1080/00325481.2021.2009683 10.1111/acel.13415 10.3109/0284186x.2014.998275 10.1002/cncr.32297 10.1158/1055-9965.EPI-17-0769 10.1007/s11357-024-01164-6 10.1016/j.freeradbiomed.2020.08.024 10.1249/mss.0000000000000297 10.1007/s10552-022-01663-x 10.1016/j.ejca.2008.02.030 10.1073/pnas.1019581108 10.3390/jcm12237346 10.1016/j.ejca.2016.07.010 10.1097/CEJ.0b013e32833b4828 10.1016/j.bbi.2013.10.030 10.1111/ecc.13037 10.1200/JCO.19.01019 10.1002/jcp.28304 10.1038/s41571-020-00459-9 10.1111/pcmr.12594 10.1158/1055-9965.Epi-14-0707 10.1093/ajcn/nqaa394 10.1007/s10549-017-4541-9 10.3390/cancers14041001 10.1016/j.annepidem.2010.03.014 10.1097/ncc.0000000000000847 10.1093/jncics/pkac009 10.1093/annonc/mdu012 10.1200/JCO.2006.06.0855 10.3389/fmed.2023.1049248 10.3322/caac.21719 10.1158/1078-0432.CCR-09-0496 10.1016/j.freeradbiomed.2024.07.041 10.1038/s41523-020-00194-5 10.1016/j.eururo.2017.06.037 10.1016/j.jsams.2018.10.002 10.3390/nu13010243 10.1097/CEJ.0b013e3283498dd4 10.3322/caac.21834 10.1186/s12890-024-03108-4 10.1186/s12885-017-3697-3 10.1016/j.bulcan.2020.06.013 10.1038/sj.bjc.6605404 10.1007/s00520-023-08192-6 10.3390/cancers13194804 10.3390/antiox12040901 10.1001/jamaoncol.2021.6590 10.1007/s10549-014-2966-y 10.3349/ymj.2023.0638 10.1158/1055-9965.EPI-13-0108 10.1158/1055-9965.Epi-08-0595 10.1002/cncr.32860 10.1200/jco.2007.15.9822 10.1186/s12885-024-12883-6 10.1007/s10549-010-0774-6 10.1007/s10552-013-0294-x 10.1158/0008-5472.CAN-18-2468 10.1161/CIRCULATIONAHA.119.043483 10.1016/s0895-4356(02)00443-2 10.1007/s10552-010-9691-6 10.1136/bjsports-2021-104046 10.1093/jncics/pkac085 10.1200/JCO.2010.31.5226 10.1016/j.ejca.2009.07.013 10.1097/ncc.0000000000000580 10.1016/j.je.2016.12.004 10.1007/s11357-023-00826-1 10.1016/j.eururo.2015.12.032 10.1007/s10552-012-0071-2 10.1002/cncr.25396 10.1136/gut.2005.068189 10.1111/acel.13159 10.1158/1055-9965.EPI-11-0079 10.1186/s12889-018-5669-1 10.1001/jama.293.20.2479 10.1186/s12885-015-1971-9 10.1016/j.cell.2022.11.001 10.2196/64016 10.1038/sj.bjc.6601820 10.1038/s41568-020-00300-6 10.1097/PPO.0000000000000397 10.18632/aging.203051 10.2337/dc10-9990 10.1073/pnas.2204750120 10.1002/ijc.23747 10.1038/sj.ph.1900675 10.1158/1055-9965.Epi-07-0771 10.1001/archinternmed.2009.412 10.3389/fendo.2018.00258 10.1054/bjoc.2001.2096 10.1038/s41391-021-00380-x 10.1097/CEJ.0000000000000898 10.1007/s10549-009-0603-y 10.1002/cam4.1043 10.1001/jamanetworkopen.2023.21102 10.1158/1940-6207.Capr-10-0295 10.1038/s41598-017-04448-4 10.1186/s12916-024-03671-x 10.1186/s12885-023-10695-8 10.1007/s10552-018-1017-0 10.1101/2024.11.30.24318246 10.1158/1940-6207.Capr-10-0355 10.1002/cncr.28783 10.1002/jcsm.13185 10.1188/19.CJON.639-646 10.1089/rej.2014.1623 10.1001/jamaoncol.2018.0126 10.1038/s41416-022-01775-w 10.1002/ijc.34320 10.5694/mja2.12039 10.1038/s41575-019-0189-8 10.1007/s00384-022-04224-5 10.1371/journal.pone.0080616 10.1002/9780470024522 10.1093/jncics/pky058 10.1016/j.smhs.2023.03.005
ContentType	Journal Article
Copyright	The Author(s) 2025 2025. The Author(s). The Author(s) 2025. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2025 2025
Copyright_xml	– notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: The Author(s) 2025. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2025 2025
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QG 7T5 7TK 7TM H94 K9. NAPCQ 7X8 5PM
DOI	10.1007/s11357-025-01647-0
DatabaseName	Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Animal Behavior Abstracts Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Nursing & Allied Health Premium Animal Behavior Abstracts Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Neurosciences Abstracts MEDLINE - Academic
DatabaseTitleList	Nursing & Allied Health Premium MEDLINE MEDLINE - Academic CrossRef
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Anatomy & Physiology Public Health
EISSN	2509-2723
EndPage	5255
ExternalDocumentID	PMC12181474 40220151 10_1007_s11357_025_01647_0
Genre	Meta-Analysis Systematic Review Journal Article
GrantInformation_xml	– fundername: Semmelweis University – fundername: NCI NIH HHS grantid: R01 CA255840 – fundername: NIA NIH HHS grantid: R01 AG055395 – fundername: NINDS NIH HHS grantid: R01 NS100782 – fundername: NIA NIH HHS grantid: R01 AG070915 – fundername: NIA NIH HHS grantid: RF1 AG072295 – fundername: NIA NIH HHS grantid: R01 AG068295
GroupedDBID	0-V 0R~ 2JN 2JY 2LR 406 53G 7RV 7WY 7X7 88E 8FI 8FJ 8FL AACDK AAFWJ AAHNG AAIAL AAJBT AANXM AANZL AAPKM AARHV AASML AATNV AATVU AAUYE AAYTO AAYZH ABAKF ABBRH ABDBE ABDZT ABECU ABFSG ABFTV ABHQN ABJNI ABJOX ABKCH ABKTR ABMQK ABNWP ABSXP ABTEG ABTKH ABTMW ABUWG ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACMDZ ACMLO ACOKC ACPIV ACSTC ACZOJ ADBBV ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEFQL AEJRE AEKMD AEMSY AEOHA AESKC AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFLOW AFOHR AFQWF AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AHPBZ AHSBF AHWEU AIAKS AIGIU AILAN AITGF AIXLP AJBLW AJZVZ ALIPV ALMA_UNASSIGNED_HOLDINGS ALSLI AMKLP AMXSW AMYLF AOCGG AOIJS ARALO ASOEW ATHPR AXYYD AYFIA AZQEC BAWUL BDATZ BENPR BEZIV BGNMA BKEYQ BPHCQ BVXVI C6C CCPQU CSCUP DDRTE DIK DNIVK DPUIP DWQXO EBLON EBS EIOEI EJD EMOBN FERAY FFXSO FIGPU FINBP FNLPD FRNLG FSGXE FYUFA GGCAI GNUQQ GNWQR HEHIP HMCUK HYE IKXTQ IWAJR J-C JZLTJ K60 K6~ LLZTM M0C M1P M2R M2S M4Y NAPCQ NPVJJ NQJWS NU0 O9J PHGZM PHGZT PQBIZ PQBZA PQQKQ PROAC PSQYO PT4 QOR RHV ROL RPM RSV SBY SCLPG SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE TSG UKHRP UOJIU UTJUX UZXMN VFIZW W23 YLTOR ZMTXR AAYXX ABRTQ CITATION KOV CGR CUY CVF ECM EIF NPM PJZUB POGQB PPXIY PRQQA 7QG 7T5 7TK 7TM H94 K9. 7X8 5PM
ID	FETCH-LOGICAL-c477t-16710d3098686dc1fca9c7d5854c5f1402e1c486f551c82a2d853f147d7b0b913
IEDL.DBID	RSV
ISICitedReferencesCount	2
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001465104600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2509-2723 2509-2715
IngestDate	Tue Nov 04 02:03:37 EST 2025 Fri Oct 03 00:23:36 EDT 2025 Fri Nov 14 03:52:42 EST 2025 Mon Jul 21 06:04:37 EDT 2025 Tue Nov 18 21:19:07 EST 2025 Sat Nov 29 07:51:42 EST 2025 Sat Jun 21 01:10:31 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	3
Keywords	Physical activity Lung cancer Colorectal cancer Breast cancer Survival Prostate cancer Skin cancer
Language	English
License	2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c477t-16710d3098686dc1fca9c7d5854c5f1402e1c486f551c82a2d853f147d7b0b913
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0009-0001-5053-2828
OpenAccessLink	https://link.springer.com/10.1007/s11357-025-01647-0
PMID	40220151
PQID	3255433792
PQPubID	326370
PageCount	21
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_12181474 proquest_miscellaneous_3189463666 proquest_journals_3255433792 pubmed_primary_40220151 crossref_citationtrail_10_1007_s11357_025_01647_0 crossref_primary_10_1007_s11357_025_01647_0 springer_journals_10_1007_s11357_025_01647_0
PublicationCentury	2000
PublicationDate	2025-06-01
PublicationDateYYYYMMDD	2025-06-01
PublicationDate_xml	– month: 06 year: 2025 text: 2025-06-01 day: 01
PublicationDecade	2020
PublicationPlace	Cham
PublicationPlace_xml	– name: Cham – name: Switzerland – name: Dordrecht
PublicationSubtitle	Official Journal of the American Aging Association (AGE)
PublicationTitle	GeroScience
PublicationTitleAbbrev	GeroScience
PublicationTitleAlternate	Geroscience
PublicationYear	2025
Publisher	Springer International Publishing Springer Nature B.V
Publisher_xml	– name: Springer International Publishing – name: Springer Nature B.V
References	E Ekblom-Bak (1647_CR98) 2023; 6 H Arem (1647_CR115) 2015; 33 M Potiaumpai (1647_CR139) 2023; 12 A Johnsson (1647_CR52) 2019; 28 JM Scott (1647_CR140) 2020; 141 EM Ibrahim (1647_CR15) 2011; 28 P Zimmer (1647_CR79) 2024; 22 SM Afify (1647_CR134) 2022; 127 CM Friedenreich (1647_CR70) 2009; 124 JA Meyerhardt (1647_CR111) 2009; 169 JG Kuiper (1647_CR113) 2012; 23 F Bray (1647_CR4) 2024; 74 JC Brown (1647_CR152) 2019; 25 L Maumy (1647_CR18) 2020; 107 L Yeganeh (1647_CR17) 2024; 185 MJ Symons (1647_CR49) 2002; 55 A Wang (1647_CR93) 2016; 139 EG Franca-Lara (1647_CR160) 2023; 5 PV Carapeto (1647_CR27) 2021; 13 JA Meyerhardt (1647_CR124) 2009; 15 JA Meyerhardt (1647_CR107) 2006; 24 J Lee (1647_CR12) 2019; 42 P Zimmer (1647_CR148) 2014; 93 A Rebelo-Marques (1647_CR25) 2018; 9 CA Klein (1647_CR7) 2020; 20 I Dimauro (1647_CR36) 2017; 7 SG Wannamethee (1647_CR94) 2001; 85 N Keum (1647_CR3) 2019; 16 Z Ungvari (1647_CR40) 2024 1647_CR100 P Yang (1647_CR9) 2012; 7 H Arem (1647_CR84) 2014; 135 1647_CR44 A Tamakoshi (1647_CR109) 2017; 27 SL Sprague (1647_CR151) 2019; 23 KK Tsilidis (1647_CR19) 2023; 152 B-H Huang (1647_CR45) 2022; 56 1647_CR48 ML Irwin (1647_CR60) 2008; 26 JD Roh (1647_CR30) 2020; 19 SM Enger (1647_CR71) 2004; 90 SC Hayes (1647_CR50) 2018; 167 PE Abrahamson (1647_CR75) 2006; 107 MD Holmes (1647_CR57) 2005; 293 RJ Cleveland (1647_CR74) 2012; 21 LA Bertram (1647_CR63) 2011; 22 A Emaus (1647_CR72) 2010; 121 Z Gao (1647_CR161) 2023; 12 C Lopez-Otin (1647_CR38) 2023; 186 ML Irwin (1647_CR55) 2011; 4 K-Y An (1647_CR47) 2024; 65 Q Li (1647_CR162) 2024; 15 R Kalani (1647_CR33) 2006; 61 SS Hellmann (1647_CR69) 2010; 19 1647_CR133 B Vainshelboim (1647_CR87) 2019; 22 HF Bochenek (1647_CR144) 2024; 30 Y Liu (1647_CR5) 2024; 67 CM Friedenreich (1647_CR101) 2016; 70 C Cao (1647_CR42) 2022; 8 Y Wang (1647_CR104) 2017; 72 AI Phipps (1647_CR108) 2018; 27 SB Santagnello (1647_CR158) 2024; 38 CM Dieli-Conwright (1647_CR77) 2022; 22 CJ Crespo (1647_CR103) 2008; 5 ME Spei (1647_CR13) 2019; 44 G Davey Smith (1647_CR92) 2000; 114 N Orsini (1647_CR105) 2009; 101 D Santa Mina (1647_CR155) 2019; 125 KS Courneya (1647_CR51) 2014; 46 AM Haydon (1647_CR110) 2006; 55 LW Jones (1647_CR90) 2010; 116 N Collao (1647_CR157) 2023; 14 1647_CR65 1647_CR129 MA Cancilla (1647_CR150) 2024; 24 X Ma (1647_CR2) 2006; 79 A Albini (1647_CR46) 2025; 34 A Safdar (1647_CR28) 2011; 108 KB Borch (1647_CR54) 2015; 15 MH Tao (1647_CR67) 2013; 24 EL Van Blarigan (1647_CR127) 2018; 4 M Van Zutphen (1647_CR119) 2021; 113 TH Keegan (1647_CR68) 2010; 123 P Zimmer (1647_CR149) 2015; 36 1647_CR153 1647_CR81 PD Baade (1647_CR112) 2011; 20 NL Stout (1647_CR163) 2020; 126 JA Meyerhardt (1647_CR117) 2006; 24 TE Robsahm (1647_CR85) 2017; 6 JC Campos (1647_CR31) 2023; 120 Y Jee (1647_CR88) 2018; 18 J Jeon (1647_CR116) 2013; 12 J Gorzelitz (1647_CR97) 2022; 56 SA Kenfield (1647_CR102) 2011; 29 C Himbert (1647_CR128) 2023; 23 AJ Done (1647_CR138) 2016; 10 AB Bigley (1647_CR145) 2014; 39 E Schwitzer (1647_CR132) 2017; 30 PT Bradshaw (1647_CR59) 2014; 145 KC Smit (1647_CR125) 2022; 14 I Ratjen (1647_CR122) 2017; 17 1647_CR142 M Arnold (1647_CR1) 2020; 159 P Glare (1647_CR8) 2008; 44 C Cao (1647_CR131) 2023; 31 1647_CR83 CN Holick (1647_CR58) 2008; 17 1647_CR82 Y Cao (1647_CR78) 2020; 6 JM Beasley (1647_CR56) 2012; 131 SE Bonn (1647_CR99) 2015; 24 PT Campbell (1647_CR114) 2013; 31 KY Wonders (1647_CR154) 2019; 18 C Lopez-Otin (1647_CR39) 2023; 35 1647_CR89 YN Tarasenko (1647_CR120) 2018; 29 R Song (1647_CR130) 2021; 30 N Garatachea (1647_CR26) 2015; 18 G Markozannes (1647_CR22) 2024; 155 G Ammitzbøll (1647_CR62) 2016; 66 G Watson (1647_CR141) 2022; 134 JA Laukkanen (1647_CR91) 2010; 46 S Dufresne (1647_CR146) 2022; 25 L Delrieu (1647_CR76) 2020; 10 SJ Nechuta (1647_CR80) 2023; 34 X Chen (1647_CR64) 2011; 4 IR Lanza (1647_CR35) 2009; 89 GD Batty (1647_CR106) 2011; 22 IM Lahart (1647_CR14) 2015; 54 M Lee (1647_CR118) 2021; 13 1647_CR6 B Sternfeld (1647_CR61) 2009; 18 CM Alfano (1647_CR95) 2004; 13 X Sui (1647_CR86) 2010; 42 1647_CR10 1647_CR11 DA Englund (1647_CR34) 2021; 20 A Hanyuda (1647_CR121) 2016; 23 C Fiuza-Luces (1647_CR37) 2024; 24 Z Ungvari (1647_CR41) 2024 AR Mallard (1647_CR136) 2020; 160 NA de Glas (1647_CR53) 2014; 120 H Zhai (1647_CR159) 2023; 10 X Zhang (1647_CR143) 2019; 79 SK Kunutsor (1647_CR32) 2024 RA Cannioto (1647_CR43) 2021; 113 MJ Rossman (1647_CR29) 2017; 313 1647_CR165 WA Wood (1647_CR164) 2016; 51 L Dal Maso (1647_CR73) 2008; 123 W Song (1647_CR96) 2024; 24 CN West-Wright (1647_CR66) 2009; 18 M Jokai (1647_CR23) 2023; 45 SK Powers (1647_CR137) 2024; 224 CL Rock (1647_CR156) 2022; 72 KT Choy (1647_CR21) 2022; 37 J Lee (1647_CR20) 2021; 44 KA Murach (1647_CR24) 2022; 21 BJ Guercio (1647_CR126) 2019; 37 J Hou (1647_CR135) 2021; 18 M Ferioli (1647_CR147) 2019; 234 D Schmid (1647_CR16) 2014; 25 M Yamauchi (1647_CR123) 2013; 22
References_xml	– ident: 1647_CR11 doi: 10.3389/pore.2024.1611623 – volume: 113 start-page: 54 year: 2021 ident: 1647_CR43 publication-title: J Natl Cancer Inst. doi: 10.1093/jnci/djaa046 – volume: 13 start-page: 2233 year: 2004 ident: 1647_CR95 publication-title: Cancer Epidemiol Biomarkers Prev. doi: 10.1158/1055-9965.2233.13.12 – volume: 33 start-page: 180 year: 2015 ident: 1647_CR115 publication-title: J Clin Oncol. doi: 10.1200/JCO.2014.58.1355 – volume: 7 start-page: 64 year: 2012 ident: 1647_CR9 publication-title: J Thorac Oncol doi: 10.1097/JTO.0b013e3182397b3e – volume: 18 start-page: 2851 year: 2009 ident: 1647_CR66 publication-title: Cancer Epidemiol Biomarkers Prev. doi: 10.1158/1055-9965.Epi-09-0538 – volume: 15 start-page: 906 year: 2024 ident: 1647_CR162 publication-title: Thorac Cancer. doi: 10.1111/1759-7714.15272 – volume: 135 start-page: 423 year: 2014 ident: 1647_CR84 publication-title: Int J Cancer. doi: 10.1002/ijc.28659 – volume: 107 start-page: 1777 year: 2006 ident: 1647_CR75 publication-title: Cancer. doi: 10.1002/cncr.22201 – year: 2024 ident: 1647_CR41 publication-title: Geroscience. doi: 10.1007/s11357-024-01384-w – volume: 313 start-page: H890 year: 2017 ident: 1647_CR29 publication-title: Am J Physiol Heart Circ Physiol. doi: 10.1152/ajpheart.00416.2017 – volume: 30 start-page: 1816 year: 2021 ident: 1647_CR130 publication-title: Cancer Epidemiol Biomarkers Prev. doi: 10.1158/1055-9965.Epi-21-0120 – volume: 23 start-page: 908 year: 2016 ident: 1647_CR121 publication-title: Ann Surg Oncol doi: 10.1245/s10434-015-4967-4 – volume: 89 start-page: 467S year: 2009 ident: 1647_CR35 publication-title: Am J Clin Nutr. doi: 10.3945/ajcn.2008.26717D – volume: 12 start-page: 705 year: 2023 ident: 1647_CR161 publication-title: J Sport Health Sci. doi: 10.1016/j.jshs.2023.07.002 – ident: 1647_CR165 doi: 10.3390/jcm9061775 – volume: 93 start-page: 527 year: 2014 ident: 1647_CR148 publication-title: Eur J Haematol. doi: 10.1111/ejh.12395 – volume: 36 start-page: 510 year: 2015 ident: 1647_CR149 publication-title: Int J Sports Med. doi: 10.1055/s-0034-1398531 – volume: 185 start-page: 107977 year: 2024 ident: 1647_CR17 publication-title: Maturitas. doi: 10.1016/j.maturitas.2024.107977 – volume: 10 start-page: 10757 year: 2020 ident: 1647_CR76 publication-title: Sci Rep. doi: 10.1038/s41598-020-67431-6 – volume: 51 start-page: 967 year: 2016 ident: 1647_CR164 publication-title: Bone Marrow Transplant. doi: 10.1038/bmt.2016.73 – volume: 67 start-page: 2274 year: 2024 ident: 1647_CR5 publication-title: Sci China Life Sci doi: 10.1007/s11427-024-2657-y – volume: 61 start-page: 211 year: 2006 ident: 1647_CR33 publication-title: J Gerontol. doi: 10.1093/gerona/61.3.211 – volume: 21 start-page: e13527 year: 2022 ident: 1647_CR24 publication-title: Aging Cell. doi: 10.1111/acel.13527 – volume: 38 start-page: 773 year: 2024 ident: 1647_CR158 publication-title: J Strength Cond Res. doi: 10.1519/JSC.0000000000004020 – volume: 12 start-page: 10715 year: 2023 ident: 1647_CR139 publication-title: Cancer Med. doi: 10.1002/cam4.5831 – volume: 35 start-page: 12 year: 2023 ident: 1647_CR39 publication-title: Cell Metab. doi: 10.1016/j.cmet.2022.11.001 – volume: 22 start-page: 32 year: 2022 ident: 1647_CR77 publication-title: BMC Womens Health. doi: 10.1186/s12905-022-01614-3 – volume: 139 start-page: 2178 year: 2016 ident: 1647_CR93 publication-title: Int J Cancer. doi: 10.1002/ijc.30281 – volume: 22 start-page: 427 year: 2011 ident: 1647_CR63 publication-title: Cancer Causes Control. doi: 10.1007/s10552-010-9714-3 – volume: 124 start-page: 1954 year: 2009 ident: 1647_CR70 publication-title: Int J Cancer. doi: 10.1002/ijc.24155 – volume: 131 start-page: 637 year: 2012 ident: 1647_CR56 publication-title: Breast Cancer Res Treat. doi: 10.1007/s10549-011-1770-1 – volume: 155 start-page: 426 year: 2024 ident: 1647_CR22 publication-title: Int J Cancer. doi: 10.1002/ijc.34903 – year: 2024 ident: 1647_CR32 publication-title: Geroscience. doi: 10.1007/s11357-024-01222-z – volume: 5 start-page: 918 year: 2008 ident: 1647_CR103 publication-title: J Phys Act Health. doi: 10.1123/jpah.5.6.918 – volume: 10 start-page: 191 year: 2016 ident: 1647_CR138 publication-title: Redox Biol. doi: 10.1016/j.redox.2016.10.003 – volume: 24 start-page: 3535 year: 2006 ident: 1647_CR107 publication-title: J Clin Oncol. doi: 10.1200/JCO.2006.06.0863 – volume: 56 start-page: 1277 year: 2022 ident: 1647_CR97 publication-title: Br J Sports Med. doi: 10.1136/bjsports-2021-105315 – volume: 28 start-page: 753 year: 2011 ident: 1647_CR15 publication-title: Med Oncol. doi: 10.1007/s12032-010-9536-x – ident: 1647_CR44 doi: 10.7717/peerj.18892 – volume: 42 start-page: 872 year: 2010 ident: 1647_CR86 publication-title: Med Sci Sports Exerc. doi: 10.1249/MSS.0b013e3181c47b65 – volume: 44 start-page: 144 year: 2019 ident: 1647_CR13 publication-title: Breast. doi: 10.1016/j.breast.2019.02.001 – volume: 18 start-page: 153473541983946 year: 2019 ident: 1647_CR154 publication-title: Integr Cancer Ther. doi: 10.1177/1534735419839466 – volume: 12 start-page: 233 year: 2013 ident: 1647_CR116 publication-title: Clin Colorectal Cancer. doi: 10.1016/j.clcc.2013.06.005 – volume: 24 start-page: 282 year: 2024 ident: 1647_CR37 publication-title: Nat Rev Immunol. doi: 10.1038/s41577-023-00943-0 – volume: 31 start-page: 876 year: 2013 ident: 1647_CR114 publication-title: J Clin Oncol. doi: 10.1200/JCO.2012.45.9735 – volume: 134 start-page: 26 year: 2022 ident: 1647_CR141 publication-title: Postgrad Med. doi: 10.1080/00325481.2021.2009683 – volume: 20 start-page: e13415 year: 2021 ident: 1647_CR34 publication-title: Aging Cell. doi: 10.1111/acel.13415 – volume: 54 start-page: 635 year: 2015 ident: 1647_CR14 publication-title: Acta Oncol. doi: 10.3109/0284186x.2014.998275 – volume: 125 start-page: 3437 year: 2019 ident: 1647_CR155 publication-title: Cancer. doi: 10.1002/cncr.32297 – volume: 27 start-page: 696 year: 2018 ident: 1647_CR108 publication-title: Cancer Epidemiol, Biomarkers & Prev. doi: 10.1158/1055-9965.EPI-17-0769 – year: 2024 ident: 1647_CR40 publication-title: Geroscience. doi: 10.1007/s11357-024-01164-6 – volume: 160 start-page: 471 year: 2020 ident: 1647_CR136 publication-title: Free Radic Biol Med. doi: 10.1016/j.freeradbiomed.2020.08.024 – volume: 46 start-page: 1744 year: 2014 ident: 1647_CR51 publication-title: Med Sci Sports Exerc. doi: 10.1249/mss.0000000000000297 – volume: 34 start-page: 277 year: 2023 ident: 1647_CR80 publication-title: Cancer Causes Control. doi: 10.1007/s10552-022-01663-x – volume: 44 start-page: 1146 year: 2008 ident: 1647_CR8 publication-title: Euro J Cancer doi: 10.1016/j.ejca.2008.02.030 – volume: 108 start-page: 4135 year: 2011 ident: 1647_CR28 publication-title: Proc Natl Acad Sci U S A. doi: 10.1073/pnas.1019581108 – ident: 1647_CR83 doi: 10.3390/jcm12237346 – volume: 66 start-page: 67 year: 2016 ident: 1647_CR62 publication-title: Eur J Cancer. doi: 10.1016/j.ejca.2016.07.010 – volume: 19 start-page: 366 year: 2010 ident: 1647_CR69 publication-title: Eur J Cancer Prev. doi: 10.1097/CEJ.0b013e32833b4828 – volume: 39 start-page: 160 year: 2014 ident: 1647_CR145 publication-title: Brain Behav Immun. doi: 10.1016/j.bbi.2013.10.030 – volume: 28 start-page: e13037 year: 2019 ident: 1647_CR52 publication-title: Eur J Cancer Care (Engl). doi: 10.1111/ecc.13037 – volume: 37 start-page: 2620 year: 2019 ident: 1647_CR126 publication-title: J Clin Oncol doi: 10.1200/JCO.19.01019 – volume: 234 start-page: 14852 year: 2019 ident: 1647_CR147 publication-title: J Cell Physiol. doi: 10.1002/jcp.28304 – volume: 18 start-page: 261 year: 2021 ident: 1647_CR135 publication-title: Nat Rev Clin Oncol. doi: 10.1038/s41571-020-00459-9 – volume: 30 start-page: 424 year: 2017 ident: 1647_CR132 publication-title: Pigment Cell Melanoma Res. doi: 10.1111/pcmr.12594 – volume: 24 start-page: 57 year: 2015 ident: 1647_CR99 publication-title: Cancer Epidemiol Biomarkers Prev. doi: 10.1158/1055-9965.Epi-14-0707 – volume: 113 start-page: 1447 year: 2021 ident: 1647_CR119 publication-title: Am J Clin Nutr. doi: 10.1093/ajcn/nqaa394 – volume: 167 start-page: 505 year: 2018 ident: 1647_CR50 publication-title: Breast Cancer Res Treat. doi: 10.1007/s10549-017-4541-9 – volume: 14 start-page: 1001 year: 2022 ident: 1647_CR125 publication-title: Cancers. doi: 10.3390/cancers14041001 – ident: 1647_CR89 doi: 10.1016/j.annepidem.2010.03.014 – volume: 44 start-page: 453 year: 2021 ident: 1647_CR20 publication-title: Cancer Nurs. doi: 10.1097/ncc.0000000000000847 – ident: 1647_CR82 doi: 10.1093/jncics/pkac009 – volume: 25 start-page: 1293 year: 2014 ident: 1647_CR16 publication-title: Ann Oncol. doi: 10.1093/annonc/mdu012 – volume: 24 start-page: 3527 year: 2006 ident: 1647_CR117 publication-title: J Clin Oncol. doi: 10.1200/JCO.2006.06.0855 – volume: 10 start-page: 1049248 year: 2023 ident: 1647_CR159 publication-title: Front Med (Lausanne). doi: 10.3389/fmed.2023.1049248 – volume: 72 start-page: 230 year: 2022 ident: 1647_CR156 publication-title: CA Cancer J Clin. doi: 10.3322/caac.21719 – volume: 15 start-page: 5931 year: 2009 ident: 1647_CR124 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-09-0496 – volume: 224 start-page: 470 year: 2024 ident: 1647_CR137 publication-title: Free Radic Biol Med. doi: 10.1016/j.freeradbiomed.2024.07.041 – volume: 6 start-page: 51 year: 2020 ident: 1647_CR78 publication-title: NPJ Breast Cancer. doi: 10.1038/s41523-020-00194-5 – volume: 72 start-page: 931 year: 2017 ident: 1647_CR104 publication-title: Eur Urol. doi: 10.1016/j.eururo.2017.06.037 – volume: 22 start-page: 403 year: 2019 ident: 1647_CR87 publication-title: J Sci Med Sport. doi: 10.1016/j.jsams.2018.10.002 – ident: 1647_CR100 doi: 10.3390/nu13010243 – volume: 21 start-page: 46 year: 2012 ident: 1647_CR74 publication-title: Eur J Cancer Prev. doi: 10.1097/CEJ.0b013e3283498dd4 – volume: 74 start-page: 229 year: 2024 ident: 1647_CR4 publication-title: CA Cancer J Clin. doi: 10.3322/caac.21834 – volume: 24 start-page: 326 year: 2024 ident: 1647_CR96 publication-title: BMC Pulm Med. doi: 10.1186/s12890-024-03108-4 – volume: 17 start-page: 1 year: 2017 ident: 1647_CR122 publication-title: BMC cancer. doi: 10.1186/s12885-017-3697-3 – volume: 107 start-page: 1042 year: 2020 ident: 1647_CR18 publication-title: Bull Cancer. doi: 10.1016/j.bulcan.2020.06.013 – volume: 101 start-page: 1932 year: 2009 ident: 1647_CR105 publication-title: Br J Cancer. doi: 10.1038/sj.bjc.6605404 – volume: 31 start-page: 718 year: 2023 ident: 1647_CR131 publication-title: Support Care Cancer. doi: 10.1007/s00520-023-08192-6 – volume: 13 start-page: 4804 year: 2021 ident: 1647_CR118 publication-title: Cancers. doi: 10.3390/cancers13194804 – ident: 1647_CR133 doi: 10.3390/antiox12040901 – volume: 8 start-page: 395 year: 2022 ident: 1647_CR42 publication-title: JAMA oncology. doi: 10.1001/jamaoncol.2021.6590 – volume: 145 start-page: 735 year: 2014 ident: 1647_CR59 publication-title: Breast Cancer Res Treat. doi: 10.1007/s10549-014-2966-y – volume: 65 start-page: 315 year: 2024 ident: 1647_CR47 publication-title: Yonsei Med J. doi: 10.3349/ymj.2023.0638 – volume: 22 start-page: 1142 year: 2013 ident: 1647_CR123 publication-title: Cancer Epidemiol Biomark & Prev doi: 10.1158/1055-9965.EPI-13-0108 – volume: 18 start-page: 87 year: 2009 ident: 1647_CR61 publication-title: Cancer Epidemiol Biomarkers Prev. doi: 10.1158/1055-9965.Epi-08-0595 – volume: 126 start-page: 2750 year: 2020 ident: 1647_CR163 publication-title: Cancer. doi: 10.1002/cncr.32860 – volume: 26 start-page: 3958 year: 2008 ident: 1647_CR60 publication-title: J Clin Oncol. doi: 10.1200/jco.2007.15.9822 – volume: 24 start-page: 1137 year: 2024 ident: 1647_CR150 publication-title: BMC Cancer. doi: 10.1186/s12885-024-12883-6 – volume: 123 start-page: 531 year: 2010 ident: 1647_CR68 publication-title: Breast Cancer Res Treat. doi: 10.1007/s10549-010-0774-6 – volume: 24 start-page: 2177 year: 2013 ident: 1647_CR67 publication-title: Cancer Causes Control. doi: 10.1007/s10552-013-0294-x – volume: 79 start-page: 2447 year: 2019 ident: 1647_CR143 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-18-2468 – volume: 30 start-page: 14 year: 2024 ident: 1647_CR144 publication-title: Exerc Immunol Rev. – volume: 141 start-page: 560 year: 2020 ident: 1647_CR140 publication-title: Circulation. doi: 10.1161/CIRCULATIONAHA.119.043483 – volume: 55 start-page: 893 year: 2002 ident: 1647_CR49 publication-title: J Clin Epidemiol. doi: 10.1016/s0895-4356(02)00443-2 – volume: 22 start-page: 311 year: 2011 ident: 1647_CR106 publication-title: Cancer Causes Control. doi: 10.1007/s10552-010-9691-6 – volume: 56 start-page: 718 year: 2022 ident: 1647_CR45 publication-title: British J Sports Med. doi: 10.1136/bjsports-2021-104046 – ident: 1647_CR81 doi: 10.1093/jncics/pkac085 – volume: 29 start-page: 726 year: 2011 ident: 1647_CR102 publication-title: J Clin Oncol. doi: 10.1200/JCO.2010.31.5226 – volume: 46 start-page: 355 year: 2010 ident: 1647_CR91 publication-title: Eur J Cancer. doi: 10.1016/j.ejca.2009.07.013 – volume: 42 start-page: 271 year: 2019 ident: 1647_CR12 publication-title: Cancer Nurs. doi: 10.1097/ncc.0000000000000580 – volume: 27 start-page: S36 year: 2017 ident: 1647_CR109 publication-title: J Epidemiol. doi: 10.1016/j.je.2016.12.004 – volume: 45 start-page: 2805 year: 2023 ident: 1647_CR23 publication-title: Geroscience. doi: 10.1007/s11357-023-00826-1 – volume: 70 start-page: 576 year: 2016 ident: 1647_CR101 publication-title: Eur Urol. doi: 10.1016/j.eururo.2015.12.032 – volume: 23 start-page: 1939 year: 2012 ident: 1647_CR113 publication-title: Cancer Causes & Control. doi: 10.1007/s10552-012-0071-2 – volume: 116 start-page: 4825 year: 2010 ident: 1647_CR90 publication-title: Cancer. doi: 10.1002/cncr.25396 – volume: 55 start-page: 62 year: 2006 ident: 1647_CR110 publication-title: Gut. doi: 10.1136/gut.2005.068189 – volume: 19 start-page: e13159 year: 2020 ident: 1647_CR30 publication-title: Aging Cell. doi: 10.1111/acel.13159 – volume: 20 start-page: 1410 year: 2011 ident: 1647_CR112 publication-title: Cancer Epidemiol, Biomarkers & Prev. doi: 10.1158/1055-9965.EPI-11-0079 – volume: 18 start-page: 761 year: 2018 ident: 1647_CR88 publication-title: BMC Public Health. doi: 10.1186/s12889-018-5669-1 – volume: 293 start-page: 2479 year: 2005 ident: 1647_CR57 publication-title: Jama. doi: 10.1001/jama.293.20.2479 – volume: 15 start-page: 967 year: 2015 ident: 1647_CR54 publication-title: BMC Cancer. doi: 10.1186/s12885-015-1971-9 – volume: 186 start-page: 243 year: 2023 ident: 1647_CR38 publication-title: Cell. doi: 10.1016/j.cell.2022.11.001 – ident: 1647_CR48 doi: 10.2196/64016 – volume: 90 start-page: 2138 year: 2004 ident: 1647_CR71 publication-title: Br J Cancer. doi: 10.1038/sj.bjc.6601820 – volume: 20 start-page: 681 year: 2020 ident: 1647_CR7 publication-title: Nat Rev Cancer doi: 10.1038/s41568-020-00300-6 – volume: 25 start-page: 316 year: 2019 ident: 1647_CR152 publication-title: Cancer J. doi: 10.1097/PPO.0000000000000397 – volume: 13 start-page: 14522 year: 2021 ident: 1647_CR27 publication-title: Aging (Albany NY). doi: 10.18632/aging.203051 – ident: 1647_CR142 doi: 10.2337/dc10-9990 – volume: 120 start-page: e2204750120 year: 2023 ident: 1647_CR31 publication-title: Proc Natl Acad Sci U S A. doi: 10.1073/pnas.2204750120 – volume: 123 start-page: 2188 year: 2008 ident: 1647_CR73 publication-title: Int J Cancer. doi: 10.1002/ijc.23747 – volume: 114 start-page: 308 year: 2000 ident: 1647_CR92 publication-title: Public Health. doi: 10.1038/sj.ph.1900675 – volume: 17 start-page: 379 year: 2008 ident: 1647_CR58 publication-title: Cancer Epidemiol Biomarkers Prev. doi: 10.1158/1055-9965.Epi-07-0771 – volume: 79 start-page: 85 year: 2006 ident: 1647_CR2 publication-title: Yale J Biol Med. – volume: 169 start-page: 2102 year: 2009 ident: 1647_CR111 publication-title: Arch Intern Med. doi: 10.1001/archinternmed.2009.412 – volume: 9 start-page: 258 year: 2018 ident: 1647_CR25 publication-title: Front Endocrinol (Lausanne). doi: 10.3389/fendo.2018.00258 – volume: 85 start-page: 1311 year: 2001 ident: 1647_CR94 publication-title: Br J Cancer. doi: 10.1054/bjoc.2001.2096 – volume: 25 start-page: 119 year: 2022 ident: 1647_CR146 publication-title: Prostate Cancer Prostatic Dis. doi: 10.1038/s41391-021-00380-x – volume: 34 start-page: 24 year: 2025 ident: 1647_CR46 publication-title: Euro J Cancer Prev. doi: 10.1097/CEJ.0000000000000898 – volume: 121 start-page: 651 year: 2010 ident: 1647_CR72 publication-title: Breast Cancer Res Treat. doi: 10.1007/s10549-009-0603-y – volume: 6 start-page: 865 year: 2017 ident: 1647_CR85 publication-title: Cancer Med. doi: 10.1002/cam4.1043 – volume: 6 start-page: e2321102 year: 2023 ident: 1647_CR98 publication-title: JAMA Netw Open. doi: 10.1001/jamanetworkopen.2023.21102 – volume: 4 start-page: 522 year: 2011 ident: 1647_CR55 publication-title: Cancer Prev Res (Phila). doi: 10.1158/1940-6207.Capr-10-0295 – volume: 7 start-page: 4137 year: 2017 ident: 1647_CR36 publication-title: Sci Rep. doi: 10.1038/s41598-017-04448-4 – volume: 22 start-page: 442 year: 2024 ident: 1647_CR79 publication-title: BMC Med. doi: 10.1186/s12916-024-03671-x – volume: 23 start-page: 300 year: 2023 ident: 1647_CR128 publication-title: BMC Cancer. doi: 10.1186/s12885-023-10695-8 – volume: 29 start-page: 475 year: 2018 ident: 1647_CR120 publication-title: Cancer Causes & Control. doi: 10.1007/s10552-018-1017-0 – ident: 1647_CR6 doi: 10.1101/2024.11.30.24318246 – volume: 4 start-page: 1409 year: 2011 ident: 1647_CR64 publication-title: Cancer Prev Res (Phila). doi: 10.1158/1940-6207.Capr-10-0355 – volume: 120 start-page: 2847 year: 2014 ident: 1647_CR53 publication-title: Cancer. doi: 10.1002/cncr.28783 – volume: 14 start-page: 781 year: 2023 ident: 1647_CR157 publication-title: J Cachexia Sarcopenia Muscle. doi: 10.1002/jcsm.13185 – volume: 23 start-page: 639 year: 2019 ident: 1647_CR151 publication-title: Clin J Oncol Nurs. doi: 10.1188/19.CJON.639-646 – volume: 18 start-page: 57 year: 2015 ident: 1647_CR26 publication-title: Rejuvenation Res. doi: 10.1089/rej.2014.1623 – volume: 4 start-page: 783 year: 2018 ident: 1647_CR127 publication-title: JAMA oncology. doi: 10.1001/jamaoncol.2018.0126 – volume: 127 start-page: 193 year: 2022 ident: 1647_CR134 publication-title: Br J Cancer. doi: 10.1038/s41416-022-01775-w – volume: 152 start-page: 635 year: 2023 ident: 1647_CR19 publication-title: Int J Cancer. doi: 10.1002/ijc.34320 – ident: 1647_CR153 doi: 10.5694/mja2.12039 – volume: 16 start-page: 713 year: 2019 ident: 1647_CR3 publication-title: Nat Rev Gastroenterol & Hepatol doi: 10.1038/s41575-019-0189-8 – volume: 37 start-page: 1751 year: 2022 ident: 1647_CR21 publication-title: Int J Colorectal Dis. doi: 10.1007/s00384-022-04224-5 – ident: 1647_CR65 doi: 10.1371/journal.pone.0080616 – volume: 159 start-page: e315 issue: 335–349 year: 2020 ident: 1647_CR1 publication-title: Gastroenterology. – ident: 1647_CR10 doi: 10.1002/9780470024522 – ident: 1647_CR129 doi: 10.1093/jncics/pky058 – volume: 5 start-page: 128 year: 2023 ident: 1647_CR160 publication-title: Sports Med Health Sci. doi: 10.1016/j.smhs.2023.03.005
SSID	ssj0001766300 ssib042110738 ssib031263419 ssib031271683 ssib054405726 ssib026777697 ssib061825066
Score	2.3068128
SecondaryResourceType	review_article
Snippet	Cancer remains a major global health challenge, and growing evidence suggests that physical activity is a key modifiable factor that may improve survival...
SourceID	pubmedcentral proquest pubmed crossref springer
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	5235
SubjectTerms	Adults Aging Analysis Biomedical and Life Sciences Breast cancer Cancer Cell Biology Clinical outcomes Colorectal cancer Colorectal carcinoma Diagnosis Exercise Female Geriatrics/Gerontology Humans Life Sciences Lung cancer Male Medical diagnosis Medical prognosis Meta-analysis Molecular Medicine Mortality Neoplasms - mortality Original Original Article Patients Physical activity Physical fitness Prostate Prostate cancer Public health Sensitivity analysis Skin Skin cancer Survival
Title	Exercise and survival benefit in cancer patients: evidence from a comprehensive meta-analysis
URI	https://link.springer.com/article/10.1007/s11357-025-01647-0 https://www.ncbi.nlm.nih.gov/pubmed/40220151 https://www.proquest.com/docview/3255433792 https://www.proquest.com/docview/3189463666 https://pubmed.ncbi.nlm.nih.gov/PMC12181474
Volume	47
WOSCitedRecordID	wos001465104600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: ABI/INFORM Collection customDbUrl: eissn: 2509-2723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001766300 issn: 2509-2723 databaseCode: 7WY dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.proquest.com/abicomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ABI/INFORM Global customDbUrl: eissn: 2509-2723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001766300 issn: 2509-2723 databaseCode: M0C dateStart: 20170101 isFulltext: true titleUrlDefault: https://search.proquest.com/abiglobal providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2509-2723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001766300 issn: 2509-2723 databaseCode: 7X7 dateStart: 20170101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 2509-2723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001766300 issn: 2509-2723 databaseCode: 7RV dateStart: 20170101 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 2509-2723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001766300 issn: 2509-2723 databaseCode: RSV dateStart: 20170101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5B4cAF-oA29CFXQlzA0jr22gm3qmrVQ6kQj2U5oCixHXWlNkWbLBL_nhmvs6ttAalcrCR2FMce29_YM98AvBo6J3DqrbiUVcVxhah55Q3eulR7UrnqEM5ndG4uLrLxOP8QncLa3tq9P5IMM_XS2U3IoeEUfjWQYHFU1B8NiW2GdPRPo-XOitHEIxU9ZP786uoqdAda3rWQvHVMGlaf02f_V-91eBrRJjuai8cGPPDNJmwdNahpX_9ir1mw_wwb61vw_SRGX2Jl41g7wzkEpZBVOBnWk45NGmZJQqYsUrG275iPIUkZOamwkpF9-tRfzm3i2bXvSl5G0pPn8OX05PPxGY_BF7hVxnRcaMQeTg7yTGfaWVHbMrfGoXah7LBGtSz1wqpM1wi5bJaWqcOFH58bZ6pBlQv5Ataam8bvAFMmlRKBo9C1U3WpaA-FcFqOUAyvZQKi74zCRmZyCpBxVSw5lakNC2zDIrRhMUjgzeKdH3Nejn-W3uv7uIhjtC0kalNKSpOnCRwusnF00ZFJ2fibGZYRWU6UalonsD0XicXnFDkpI2BKIFsRlkUBYu5ezWkml4HBWxCwUkYl8LaXmWW9_v4bL-9XfBeepEHsaM9oD9a66czvw2P7s5u00wN4aD6OKP36jdKxCWmG6fvB8UEYUr8B4AEWCg
linkProvider	Springer Nature
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swED5KN1hfuh_dVm_dqsLYyyaILEWy91ZKS0uzUFhX-jKMLck0sLojdgb773enyAlpt8H6ZlsylqWT9N3p7juAd0PnBC69FZeyqjjuEDWvvMFbl2pPKlcd0vlcjMx4nF1e5mcxKKztvd37I8mwUi-D3YQcGk7pVwMJFkdF_YGiNDuko3-5WFpWjCYeqRgh8-dXV3ehO9DyrofkrWPSsPscPb5fu5_AZkSbbH8uHk9hzTfPYGu_QU37-hd7z4L_ZzCsb8G3w5h9iZWNY-0M1xCUQlbhYlhPOjZpmCUJmbJIxdp-Yj6mJGUUpMJKRv7pU38194ln174reRlJT57D16PD84NjHpMvcKuM6bjQiD2cHOSZzrSzorZlbo1D7ULZYY1qWeqFVZmuEXLZLC1Thxs_PjfOVIMqF_IFrDc3jd8GpkwqJQJHoWun6lKRDYVwWo5QDK9lAqIfjMJGZnJKkPG9WHIqUx8W2IdF6MNikMCHxTs_5rwc_6y9049xEedoW0jUppSUJk8T2FsU4-yiI5Oy8TczrCOynCjVtE7g5VwkFp9TFKSMgCmBbEVYFhWIuXu1pJlcBQZvQcBKGZXAx15mlu36-2-8-r_qu_Do-PzzqBidjE9fw0YaRJDsRzuw3k1n_g08tD-7STt9GybQb2sbFDY
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED-hgRAvMBgfgQ2MhHgBa3Xs2glv07YKxFRNfEx7QVHiD60Sy6Y2ReK_585xW8oACfGWxI4S22f7d-e73wG8GDoncOltuJRNw3GHCLzxBm9drj2pXCGm8zk5MuNxcXpaHv8UxR-93RdHkn1MA7E0td3upQu7q8A3IYeGUyrWSIjFUWm_rlCTIaeuDx9PVlYWo4lTKkXL_P7V9R3pCsy86i35y5Fp3IlGd_6_DZtwO6FQtteLzV245tt7sLXXogZ-_p29ZNEvNBrct-DLYcrKxOrWsdkc1xaUTtbgIhkmHZu0zJLkTFmiaJ29YT6lKmUUvMJqRn7rU3_W-8qzc9_VvE5kKPfh8-jw0_5bnpIycKuM6bjQiEmcHJSFLrSzIti6tMah1qHsMKC6lnthVaEDQjFb5HXuEBDgc-NMM2hKIR_ARnvR-kfAlMmlREApdHAq1IpsK4TfSoRoeC0zEIuBqWxiLKfEGV-rFdcy9WGFfVjFPqwGGbxavnPZ83X8tfb2YryrNHdnlUQtS0lpyjyD58tinHV0lFK3_mKOdURREtWa1hk87MVj-TlFwcsIpDIo1gRnWYEYvddL2slZZPYWBLiUURm8XsjP6r_-3IzH_1b9Gdw8PhhVR-_G75_ArTxKIJmVtmGjm879Dtyw37rJbPo0zqUfR0EdGg
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exercise+and+survival+benefit+in+cancer+patients%3A+evidence+from+a+comprehensive+meta-analysis&rft.jtitle=GeroScience&rft.au=Ungvari%2C+Zoltan&rft.au=Fekete%2C+M%C3%B3nika&rft.au=Varga%2C+P%C3%A9ter&rft.au=Munk%C3%A1csy%2C+Gy%C3%B6ngyi&rft.date=2025-06-01&rft.issn=2509-2723&rft.eissn=2509-2723&rft_id=info:doi/10.1007%2Fs11357-025-01647-0&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2509-2723&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2509-2723&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2509-2723&client=summon